BHST — BIOHARVEST SCIENCES INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1723464 ·
Last close
$3.91
Market Cap
$88.63M
52W High
$4.90
52W Low
$3.57
ADV30
31,726
Next earnings
2026-08-10
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 8,507,000 | 5,037,000 | -1,834,000 | -2,641,000 | 45,558,000 | 19,167,000 | 22,535,000 |
| Dec 2025 | 9,066,000 | 5,225,000 | -1,121,000 | -2,204,000 | 47,665,000 | 23,025,000 | 22,217,000 |
| Sep 2025 | 9,067,000 | 5,570,000 | -920,000 | -2,513,000 | 35,188,000 | 10,966,000 | 27,453,000 |
| Jun 2025 | 8,515,000 | 5,086,000 | -1,815,000 | -4,080,000 | 27,798,000 | 3,727,000 | 32,021,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-7,226,000
Investing CF
$-2,365,000
Financing CF
$30,187,000
CapEx
$-2,355,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.67
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-107,553,000
Inventory
$4,559,000
Receivables
$2,243,000
ST Investments
—
EBIT TTM
$-8,336,000
Pretax Income TTM
$-11,059,000
Interest Exp TTM
$2,723,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$34,508,000
EBITDA
$-5,111,000
Free Cash Flow
$-10,782,250
Enterprise Value
$85,367,224
Total Cash
$23,035,000
Total Debt
$14,104,000
Shares Out
22,667,842
Trailing EPS
$-0.58
Book Value
$1.12
ROE
-83.2%
ROA
-9.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 34,508,000 | -5,575,000 | -11,135,000 | 47,665,000 | 22,217,000 | — | -7,226,000 |
| Dec 2024 | 25,188,000 | -6,989,000 | -12,913,000 | 25,001,000 | 23,671,000 | — | -6,684,000 |
| Dec 2023 | 12,672,000 | -9,966,000 | -12,564,000 | 15,002,000 | 29,855,000 | — | -8,522,000 |
| Dec 2022 | 5,498,000 | -10,612,000 | -11,236,000 | 9,393,000 | 15,322,000 | — | -9,241,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.17
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TELO | Telomir Pharmaceuticals, Inc. | $88.72M | $1.29 | — |
| FBIO | Fortress Biotech, Inc. | $89.36M | $2.69 | — |
| ANVS | Annovis Bio, Inc. | $87.64M | $2.06 | — |
| LFVN | Lifevantage Corp | $87.43M | $6.93 | — |
| IBIO | iBio, Inc. | $90.41M | $1.82 | — |
News headlines (Yahoo Finance, 1h cache)
BioHarvest Sciences and Tate & Lyle expand sweetener development program
2026-05-19 12:39 · Yahoo
BioHarvest (BHST) Q1 2026 Earnings Transcript
2026-05-18 13:08 · Yahoo
Tate & Lyle Expands Collaboration with BioHarvest Sciences to Accelerate Next-Generation Sweetener Innovation
2026-05-18 11:00 · Yahoo
BioHarvest Sciences Inc. Common Stock Q1 2026 Earnings Call Summary
2026-05-15 12:30 · Yahoo
BioHarvest Sciences Inc (BHST) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic ...
2026-05-14 23:03 · Yahoo
BioHarvest Sciences Q1 Earnings Call Highlights
2026-05-14 14:07 · Yahoo
BioHarvest Sciences Q1 revenue climbs as it expands botanical synthesis pipeline
2026-05-14 12:39 · Yahoo
BioHarvest Sciences Inc. (BHST) Reports Q1 Loss, Beats Revenue Estimates
2026-05-14 11:10 · Yahoo
BioHarvest Sciences Reports First Quarter 2026 Financial Results and Provides Business Update
2026-05-14 11:00 · Yahoo
Bionano Genomics, Inc. (BNGO) Reports Q1 Loss, Tops Revenue Estimates
2026-05-13 21:35 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.